Brensocatib Significantly Reduces Exacerbations in Bronchiectasis, confirms study Dr Riya Dave5 May 2025 8:45 PM ISTResearchers have discovered in a new study that treating airway inflammation with the experimental drug brensocatib lowers the rate of pulmonary...
Brensocatib may reduce frequency of pulmonary exacerbations in patients with non-cystic fibrosis bronchiectasis, uncovers phase 3 ASPEN study Dr. Kamal Kant Kohli6 Jun 2024 8:15 PM ISTInsmed Incorporated a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced...
Brensocatib Did Not Improve Condition of Patients with Severe COVID-19: STOP-COVID19 Trial Dr. Kamal Kant Kohli20 May 2022 8:45 AM ISTSan Francisco, CA: Brensocatib did not improve the clinical status of patients hospitalized with severe SARS-CoV-2 infection in the double-blind...
Brensocatib improves clinical outcomes in bronchiectasis patients: NEJM Medha Baranwal27 Nov 2020 9:55 AM ISTDelhi: The use of brensocatib was shown to improve clinical outcomes in bronchiectasis patients, in a 24-week trial. The findings of the...
DPP-1 inhibitor brensocatib lowers exacerbation frequency in bronchiectasis: NEJM Medha Baranwal11 Sept 2020 10:45 AM ISTDelhi: The administration of brensocatib in bronchiectasis patients improves clinical outcomes of the disease, suggests a recent study in the New...
Brensocatib may reduce exacerbation rate in bronchiectasis patients Medha Baranwal28 Jun 2020 2:27 PM ISTDelhi: Brensocatib significantly prolongs time to first pulmonary exacerbation over the 24-week treatment period versus placebo in patients...
